Benzodiazepines: Risks and benefits. A reconsideration

by Baldwin, D.S, Aitchison, K., Bateson, A., Curran, H.V, Davies, S., Leonard, B., Nutt, D.J, Stephens, D.N, Wilson, S.
Published 2013

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British...

by Baldwin, D.S, Anderson, I.M, Nutt, D.J, Allgulander, C., Bandelow, B., den Boer, J.A, Christmas, D.M, Davies, S., Fineberg, N.A, Lidbetter, N., Malizia, A., McCrone, P., Nabarro, D., O'Neill, C., Scott, J., van der Wee, N., Wittchen, H-U
Published 2014

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

by Lingford-Hughes, A.R, Welch, S., Peters, L., Nutt, D.J, Ball, D., Buntwal, N., Chick, J., Crome, I., Daly, C., Dar, K., Day, E., Duka, T., Finch, E., Law, F., Marshall, E.J, Munafo, M., Myles, J., Porter, S., Raistrick, D., Reed, L.J, Reid, A., Sell, L., Sinclair, J., Tyrer, P., West, R., Williams, T., Winstock, A.
Published 2012